| Code | 9367B | ||||||||||
| MA number | 87/0326/12-S | ||||||||||
| Product Form: | con inf 4x5 ml/4 mg (6 ml liek.inj.-COC) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Vipharm S.A., Poland | ||||||||||
| Therapeutic Class: | 87 - VARIA I | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 29.06.2012 |
| SPC: |
SPC_Zomikos 4 mg_5 ml infúzny koncentrát_03.2021.docx
|
| PIL: |
PIL_Zomikos 4 mg_5 ml infúzny koncentrát_03.2021.docx
|
| Safety feature | Yes |
| Data update: | 15.05.2018 |
